Skip to main content
SpringerLink
Log in

Orthobiologics: Background

  • Chapter
  • First Online:
Musculoskeletal Injections Manual

  • 140 Accesses

Abstract

General interest for injectable orthobiologics and their application in treatment of musculoskeletal degenerative diseases has considerably increased in the recent years due to their ability to promote tissue repair counteracting the inflammatory microenvironment and favoring the tissue homeostasis restoration. Orthobiologics category includes a variety of biological products obtained from patient’s own tissues, such as blood, bone marrow, and adipose tissue, that exert immunomodulatory and regenerative properties at the site of injection. Preclinical and clinical results together with the minimal invasiveness and easiness of the procedures suggest that orthobiologic procedures can be successfully used in treating osteoarthritis, tendinopathy, and muscle injuries, representing a valid alternative to conservative conventional treatments. However, the efficacy of orthobiologics is affected by product composition that can vary according to manufacturing methods and donor characteristics. The challenge for orthobiologics application in orthopedic field at the present is to clearly define the specific potential of each product and their therapeutic and functional characteristics in order to standardize production and establish more precise therapeutic indication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Calcei JG, Rodeo SA. Orthobiologics for bone healing. Clin Sports Med. 2019;38:79–95.

    Article  PubMed  Google Scholar 

  2. Jeyakumar V, Niculescu-Morzsa E, Bauer C, et al. Platelet-rich plasma supports proliferation and redifferentiation of chondrocytes during in vitro expansion. Front Bioeng Biotechnol. 2017;6(5):75.

    Article  Google Scholar 

  3. Zhou Y, Wang JHC. PRP treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016:9103792.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil. 2013;21(11):1627–37.3

    Article  CAS  Google Scholar 

  5. Qiu G, Zheng G, Ge M, et al. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018;9(1):320.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral med. Oral Pathol Oral Radiol Endodontol. 1998;85:638–46.

    Article  CAS  Google Scholar 

  7. Mariani E, Pulsatelli L. Platelet concentrates in musculoskeletal medicine. Int J Mol Sci. 2020;21(4):1328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Giannini S, Cielo A, Bonanome L. Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols. Eur Rev Med Pharmacol Sci. 2015;19(6):927–30.

    CAS  PubMed  Google Scholar 

  9. Lin KY, Chen P, Chen AC, et al. Leukocyte-rich platelet-rich plasma has better stimulating effects on tenocyte proliferation compared with leukocyte-poor platelet-rich plasma. Orthop J Sports Med. 15. 2022;10(3):23259671221084706.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Le ADK, Enweze L, DeBaun MR, et al. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–34.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wakayama T, Saita Y, Kobayashi Y, et al. Quality comparison between two different types of platelet-rich plasma for knee osteoarthritis. Regen Med Res. 2020;8:3.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Evans CH, Chevalier X, Wehling P. Autologous conditioned serum. Phys Med Rehabil Clin N Am. 2016;27(4):893–908.

    Article  PubMed  Google Scholar 

  13. Meijer H, Reinecke J, Becker C, et al. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction. Inflamm Res. 2003;52(10):404–7.

    Article  CAS  PubMed  Google Scholar 

  14. Li S, Xiang C, Wei X, et al. Early supplemental α2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model. Int J Rheum Dis. 2019;22(4):654–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Montesano P, Cuellar J, Scuderi G. Injection of an autologous Alpha-2-macroglobulin (A2M) concentrate alleviates Back pain in FAC-positive patients. Orthop Rheum Open Access J. 2017;4:2.

    Google Scholar 

  16. Muthu S, Jeyaraman M, Jain R, et al. Accentuating the sources of mesenchymal stem cells as cellular therapy for osteoarthritis knees-a panoramic review. Stem Cell Investig. 2021;9(8):13.

    Article  Google Scholar 

  17. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–5. 1726829

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gupta PK, Chullikana A, Rengasamy M, et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016;18(1):301.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chahla J, Alland JA, Verma NN. Bone marrow aspirate concentrate for orthopaedic use. Orthop Nurs. 2018;37(6):379–81.

    Article  PubMed  Google Scholar 

  20. Lamplot JD, Rodeo SA, Brophy RH. A practical guide for the current use of biologic therapies in sports medicine. Am J Sports Med. 2020;48(2):488–503.

    Article  PubMed  Google Scholar 

  21. Manchikanti L, Centeno CJ, Atluri S, et al. Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: evidence-based policy position statement of American Society of Interventional Pain Physicians (ASIPP). Pain Physician. 2020;23(2):E85–E131.

    PubMed  Google Scholar 

  22. Tang Q, Zhao XS, Guo A, et al. Therapeutic applications of adipose-derived stromal vascular fractions in osteoarthritis. World J Stem Cells. 2022;14(10):744–55.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ulivi M, Meroni V, Viganò M, et al. Micro-fragmented adipose tissue (mFAT) associated with arthroscopic debridement provides functional improvement in knee osteoarthritis: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2022;30:1–12.

    Google Scholar 

  24. Vezzani B, Shaw I, Lesme H, et al. Higher pericyte content and secretory activity of microfragmented human adipose tissue compared to enzymatically derived stromal vascular fraction. Stem Cells Transl Med. 2018;7(12):876–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Iyyanki T, Hubenak J, Liu J, et al. Harvesting technique affects adipose-derived stem cell yield. Aesthet Surg J. 2015;35(4):467–76.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Trivisonno A, Alexander RW, Baldari S, et al. Intraoperative strategies for minimal manipulation of autologous adipose tissue for cell- and tissue-based therapies: concise review. Stem Cells Transl Med. 2019;8(12):1265–71.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lattermann C, Leite CBG, Frisbie D, et al. Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics. J Cartil Joint Preserv. 2022;2(3):100055. ISSN 2667-2545

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Orthopaedic Biotechnology Laboratory, Ospedale Galeazzi Sant’Ambrogio, Milan, Italy

    Paola De Luca, Michela Maria Taiana & Laura de Girolamo

Authors
  1. Paola De Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michela Maria Taiana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura de Girolamo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura de Girolamo .

Editor information

Editors and Affiliations

  1. Acibadem Mehmet Ali Aydinlar University Faculty of Medicine, Department of Orthopedics and Traumatology, Istanbul, Türkiye

    Baris Kocaoglu

  2. Hilll Yaffe Medical Center (HYMC), Technion University Hospital, Hadera, Israel

    Lior Laver

  3. Orthopaedic Biotechnology Laboratory, Ospedale Galeazzi Sant'Ambrogio, Milano, Italy

    Laura de Girolamo

  4. Clinica Ortopedica, 1°, Istituto Ortopedico Gaetano Pini, Milano, Italy

    Riccardo Compagnoni

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De Luca, P., Taiana, M.M., de Girolamo, L. (2024). Orthobiologics: Background. In: Kocaoglu, B., Laver, L., Girolamo, L.d., Compagnoni, R. (eds) Musculoskeletal Injections Manual. Springer, Cham. https://doi.org/10.1007/978-3-031-52603-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-52603-9_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-52602-2

  • Online ISBN: 978-3-031-52603-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation